Beijing Tiantan Biological Products Corp Ltd is a high-risk pharmaceutical company in China specializing in blood products. They are involved in research, development, manufacturing, sales, and consulting services for products such as Shanghai Blood Human Albumin and Rongsheng tetanus human immunoglobulin. With an ESG score of 31.0, the company operates in the field of sustainability, environment, and governance.